RetractedTrialEuropean journal of endocrinology2021
Efficacy and safety of tripterygium glycosides for active moderate to severe Graves' ophthalmopathy: a randomised, observer-masked, single-centre trial.
Xiaozhen Ye et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.